Profile data is unavailable for this security.
About the company
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by-side, healing by supporting the surrounding tissue after injury, minimizing the expansion of areas of necrosis, and providing a biomaterial substrate for the body's own healing/repair processes following injury. It is composed of two biocompatible and bioresorbable polymers that are cast to form a porous investigational product: Poly lactic-co-glycolic acid and Poly-L-Lysine. Poly lactic-co-glycolic acid is a polymer that is used in resorbable sutures and provides biocompatible support for Neuro-Spinal Scaffold implants and Poly-L-Lysine is a positively charged polymer used to coat surfaces.
- Revenue in USD (TTM)0.00
- Net income in USD-9.33m
- Incorporated2003
- Employees6.00
- LocationInVivo Therapeutics Holdings CorpBuilding 1400 East 4Th FloorOne Kendall SquareCAMBRIDGE 02139United StatesUSA
- Phone+1 (617) 863-5524
- Websitehttps://www.invivotherapeutics.com/